Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

UBS Boosts Johnson & Johnson Price Target to $320 Ahead of Q3 Earnings

Guavy AI Editorial Team
Instruments
JNJ
Share

Johnson & Johnson (JNJ) is set to release its Q3 results on October 13, with a press release scheduled for 6:45 a.m. ET and an earnings call/webcast featuring CEO and CFO at 8:30 a.m. ET.

The announcement comes after UBS raised its price target for JNJ shares to $320 from $280, sending the stock up by over 2% and contributing to gains in the healthcare sector and the Dow.

This move by UBS is significant, as it suggests confidence in Johnson & Johnson's financials and future prospects. The company's Q3 results will provide crucial insight into its performance, and investors are likely eagerly awaiting the announcement.

More on Stocks

Stocks just now

Disney Animation Magic Opens September 14th at Hollywood Studios

Stocks just now

Rory McIlroy Favored to Win 2026 Amgen Irish Open

Stocks 1m ago

Amgen Stock Drops Amid Competitive Pressures and Pipeline Concerns

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy